XRCC1 coordinates disparate responses and multiprotein repair complexes depending on the nature and context of the DNA damage. by Hanssen-Bauer, Audun et al.
UCSF
UC San Francisco Previously Published Works
Title
XRCC1 coordinates disparate responses and multiprotein repair complexes depending on 
the nature and context of the DNA damage.
Permalink
https://escholarship.org/uc/item/5hj4c2t5
Journal
Environmental and molecular mutagenesis, 52(8)
ISSN
0893-6692
Authors
Hanssen-Bauer, Audun
Solvang-Garten, Karin
Sundheim, Ottar
et al.
Publication Date
2011-10-01
DOI
10.1002/em.20663
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Research Article
XRCC1Coordinates Disparate Responses and
Multiprotein Repair Complexes Depending on the
Nature and Context of the DNADamage
Audun Hanssen-Bauer,1 Karin Solvang-Garten,1 Ottar Sundheim,1
Javier Pe•a-Diaz,1 Sonja Andersen,1 Geir Slupphaug,1 Hans E. Krokan,1
David M.Wilson III,2 Mansour Akbari,1 and Marit Otterlei1*
1Department of Cancer Research and Molecular Medicine, Faculty of Medicine,
Norwegian University of Science and Technology, Trondheim, Norway
2Laboratory of Molecular Gerontology, National Institute on Aging, NIH,
Baltimore, Maryland, USA
XRCC1 is a scaffold protein capable of interacting
with several DNA repair proteins. Here we pro-
vide evidence for the presence of XRCC1 in differ-
ent complexes of sizes from 200 to 1500 kDa,
and we show that immunoprecipitates using
XRCC1 as bait are capable of complete repair of
AP sites via both short patch (SP) and long patch
(LP) base excision repair (BER). We show that
POLb and PNK colocalize with XRCC1 in replica-
tion foci and that POLb and PNK, but not PCNA,
colocalize with constitutively present XRCC1-foci
as well as damage-induced foci when low doses
of a DNA-damaging agent are applied. We dem-
onstrate that the laser dose used for introducing
DNA damage determines the repertoire of DNA
repair proteins recruited. Furthermore, we demon-
strate that recruitment of POLb and PNK to regions
irradiated with low laser dose requires XRCC1
and that inhibition of PARylation by PARP-inhibitors
only slightly reduces the recruitment of XRCC1,
PNK, or POLb to sites of DNA damage. Recruit-
ment of PCNA and FEN-1 requires higher doses of
irradiation and is enhanced by XRCC1, as well as
by accumulation of PARP-1 at the site of DNA dam-
age. These data improve our understanding of
recruitment of BER proteins to sites of DNA dam-
age and provide evidence for a role of XRCC1 in
the organization of BER into multiprotein com-
plexes of different sizes. Environ. Mol. Mutagen.
52:623–635, 2011. ' 2011 Wiley Periodicals, Inc.
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INTRODUCTION
X-ray repair cross-complementing protein 1 (XRCC1)
has no known enzymatic activity but is involved in sin-
gle-strand break repair (SSBR) and base excision repair
(BER), both considered to be part of the same pathway.
Base damage of different types, abasic sites (AP sites),
and SSBs are continuously formed in the human genome
in numbers exceeding 104 per day. Repair of such lesions
involves a number of proteins in addition to XRCC1 and
is mainly carried out by the BER/SSBR pathway. BER
takes place via short patch (SP, single nucleotide inser-
tion) or long patch (LP, usually insertion of 2–8 nucleo-
tides) repair [Frosina et al., 1999].
Xrcc12/2 mice are embryonic lethal [Tebbs et al., 1999]
and Xrcc1 deficient rodent cell lines display reduced SSBR
capacity, increased frequency of sister chromatid exchange,
and sensitivity to several types of DNA damaging agents,
particularly those that generate SSBs and base lesions [Calde-
cott, 2001]. Inefficient XRCC1-associated SSBR contributes
to neurodegenerative disease in humans [El-Khamisy et al.,
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2005; Hirano et al., 2007]. Xrcc12/2 cells were recently
shown to have a slightly reduced rate of repair of uracil in
DNA, but not repair of AP sites [Akbari et al., 2010].
A number of protein–protein interactions and posttransla-
tional modifications of proteins involved in BER have been
reported [Fan and Wilson, 2005; Prasad et al. 2007; Hagen
et al., 2008]. XRCC1 likely modulates DNA repair by its
ability to interact with several BER proteins including DNA
glycosylases [Marsin et al., 2003; Campalans et al., 2005;
Akbari et al., 2010], AP endonuclease-1 (APE-1) [Vidal
et al., 2001], DNA polymerase b (POLb) [Caldecott et al.,
1996], DNA ligase III (Lig III) [Caldecott et al., 1994], pro-
liferating cell nuclear antigen (PCNA) [Fan et al., 2004],
poly (ADP-ribose) polymerase 1 (PARP-1) [Masson et al.,
1998], PARP-2 [Schreiber et al., 2002], and polynucleotide
kinase (PNK) [Whitehouse et al., 2001]. However, whether
these interactions can result in the formation of large and
stable complexes remains elusive.
In vitro as well as in vivo results from live cell fluores-
cence energy transfer (FRET) analysis suggested that
XRCC1 forms multimers [Fan et al. 2004; Beernink et al.
2005; Akbari et al. 2010]. Different XRCC1 associated
complexes for repair of SSBs have also been identified by
immunoprecipitation experiments [Luo et al., 2004; El-
Khamisy et al., 2005]. Recently, XRCC1 was identified in
replication associated complexes and analysis of the con-
tent and function of these complexes showed that they
contain many of the above-mentioned BER proteins, as
well as some replication proteins and could efficiently
perform repair of AP sites and uracil [Parlanti et al.,
2007; Akbari et al., 2010]. However, less is known about
stable multiprotein XRCC1 complexes in cells outside
S-phase, even though various numbers of XRCC1-foci in
these cells suggest the presence of preformed XRCC1
complexes [Fan et al., 2004; Akbari et al., 2010]. In a
previous report, fractionation of whole cell extracts by gel
filtration identified only XRCC1-Lig III heterodimers of
approximately 100–200 kDa in size (corresponding to the
sum of the relative molecular weight of Lig III and
XRCC1 monomers and heterodimers) [Parsons et al.,
2005a]. Notably, in this and several other studies that
attempted to isolate XRCC1 complexes, cell extracts did
not include the chromatin-bound fraction of proteins.
Our aim for this study was to explore the role of
XRCC1 in the organisation of BER-proficient complexes
in freely cycling cells, in the absence or presence of exog-
enously induced DNA damage. We present a model of
three modes of BER involving XRCC1.
MATERIALS ANDMETHODS
Chemicals and Antibodies
The synthetic oligonucleotides were from Eurogentech (Belgium),
[a-33P]dCTP and [a-33P]dTTP (3000 Ci/mmol) from Amersham Bio-
sciences, restriction enzymes from New England BioLabs, paramagnetic
protein-A beads from Dynal (Norway), MMS and H2O2 from Sigma-
Aldrich. a-POLb IgG (ab3181), a-DNA Lig III IgG (ab587), a-XRCC1
IgG (ab1838), a-gH2AX antibody (ab2893) and a-GFP IgG (ab290)
were from Abcam (UK). Other antibodies used were a-PNK IgG (MAB-
005, Cytostore, USA), a-PCNA IgG (PC10, Santa Cruz, USA), in-house
affinity purified rabbit polyclonal antibodies (IgG fraction) raised against
GFP protein, and UNG2 [Slupphaug et al., 1995]. Secondary antibodies
(polyclonal rabbit a-mouse IgG/HRP or peroxidase-labelled polyclonal
swine a-rabbit IgG) were from Dako Cytomation (Denmark). IgGs were
crosslinked to protein-A magnetic beads according to the procedure pro-
vided by New England Biolabs. The neutralising a-POLb antibody was
a generous gift from Dr. Samuel H. Wilson (Laboratory of Structural
Biology, NIH). 4-amino-1, 8-naphthalimide (4-AN) (Sigma) and N-
(6-oxo-5,6-dihydrophenanthridin-2-yl)22-(N,N-dimethylamino)acetamid
(PJ34) (Santa Cruz) were dissolved to 10 mM in DMSO.
Cloning of Fusion Constructs
pEC/YFP-PCNA, pHcRed-PCNA (small protein from the reef coral
Heteractis crispa), pXRCC1-EYFP, and pEYFP-FEN-1 have been
described [Aas et al. 2003; Fan et al., 2004; Opresko et al., 2004;
Sharma et al., 2004]. The NdeI- (blunted)-SalI fragment of POLb from
pT7-7 [Nguyen et al., 2000] was ligated into XhoI (blunted)-SalI
digested pECFP and pEYFP-C1 plasmids (Clontech). The PNK open
reading frame (encoding 563 amino acids) was PCR amplified and sub-
cloned into the NcoI and HindIII sites of the pBlueBacHis2 B vector
(InVitrogen). The PNK-containing BglII-HindIII fragment was trans-
ferred into the pEC/EYFP-C1 plasmid to prepare an N-terminal fusion
product. All constructs were verified by sequencing. pEYFP-PARP-1
was prepared by subcloning from the pDsRed1C1-PARP-1 construct
[von Kobbe et al., ], kindly provided by Dr. Cayatano von Kobbe, NIH,
NIA, using the Sal I site.
Cell Cultures
Cells were transfected with different fusion constructs using calcium
phosphate (Profection Promega) or Fugene6 (Roche). HeLa and CHO
(CHO AA8, CHO EM9) cells stably expressing XRCC1-EYFP or EYFP
were prepared by transfection followed by cell sorting or cloning by
dilution and prolonged culturing in selective DMEM medium (Gibco)
containing 10% fetal calf serum, gentamycin (0.1 mg/ml, Gibco), gluta-
mine (1 mM), fungizone (2.5 lg/l), and geneticin (G418, 0.4 mg/ml,
added two days after tranfection). For transient transfections, cells were
examined after 16–24 hr. Untransfected cells were cultured in the same
medium without geneticin. Cells were treated with 10 lM 4-AN or PJ34
60 min at 378C prior to micro-irradiation experiments.
Confocal Microscopy
Fluorescent images of living cells cotransfected with ECFP, EYFP,
and HcRed constructs (1 lm optical slide thickness) were produced
using a Zeiss LSM 510 Meta laser scanning microscope equipped with a
Plan-Apochromate 633 1.4 oil immersion objective. Three colour
images were taken using three consecutive scans with the following set-
tings: ECFP-excitation at k 5 458 nm, detection at k 5 470–500 nm,
EYFP-excitation at k 5 488 nm, at k 5 530–600 nm and HcRed-excita-
tion at k 5 543 nm, detection at k > 615 nm. Alexa fluor 647 was
excited with 633-nm laser and emission detected at > 650 nm.
cH2AX Staining
Cells were micro-irradiated, fixed with 2% paraformaldehyde for 10
min on ice, washed once with PBS, permeabilized with methanol at
2208C for 20 min, washed once with PBS-FCS (2% fetal calf serum in
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PBS) and blocked by incubation in PBS-FCS for 30 min prior to incuba-
tion with primary rabbit gH2AX antibody diluted in PBS-FCS (1:200)
and incubated at 48C overnight. After washing the cells, they were incu-
bated with Alexa fluor 647 goat anti-rabbit (1:2000).
405-nmMicro-Irradiation
A Zeiss 405-nm diode laser was focused through a 633 1.4 Plan-Apo-
chromate Oil DIC objective to a diffraction-limited spot size in a LSM
510 Meta microscope. The 405-nm diode output was measured to 30
mW using a FieldMaster GS energy meter (Coherent Inc.) with a low
power probe. We used low dose, which recruited POLb and PNK (10
(HeLa) or 60 (CHO) laser beam iterations; or high dose (150 (HeLa) or
600 (CHO) laser beam iterations), which also recruited PCNA and FEN-
1. Time of speed was 1.27 lsec/pixel over a 50 3 2 pixel area in the
cell nucleus. Time lapse image acquisition started one scan prior to the
micro-irradiation. Signal intensities were measured using the LSM 510
Meta operating software version 4.2. The relative signal strength of the
foci were obtained by dividing average foci signal strength with average
signal strength measured in a nonirradiated, equally sized region of the
nucleus. Only cells with similar signal intensities were analyzed. Size
bars on the image equals 5 lm.
Whole Cell Extracts
Harvested cells were washed once in PBS, suspended in 83 packed
cell volume in buffer I (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 100
mM KCl, 0.2 mM EDTA, 20% (v/v) glycerol, 0.5% Nonidet P-40, 1 mM
DTT, and 1 3 Complete protease inhibitor, Roche) containing 5 ll
Omnicleave Endonuclease (200 U/ll Epicentre Technologies, WI) and
sonicated. DNase/RNase cocktail I (2 ll of Omnicleave Endonuclease, 1
ll Benzonase (250 U/ml, Novagene, Ge), 10 ll RNase (10 mg/ml,
Sigma-Aldrich), 1 ll DNase (10 U/ll, Roche), and 1 ll Micrococcal Nu-
clease (100-300 U/mg, Sigma-Aldrich) per 30 mg cell extract) was
added to the homogenate and incubated for 30 min at room temperature
(RT) before incubation at 48C overnight during dialysis against buffer II
(20 mM HEPES pH 7.9, 1.5 mM MgCl2, 100 mM KCl, 0.2 mM EDTA,
10% (v/v) glycerol, 1 mM DTT, and 0.1 3 Complete protease inhibitor,
Roche). The extract was cleared by centrifugation at 14,000 3 g prior to
IP with anti-EYFP coupled beads.
Gel Filtration
Cell extracts for gel filtration were prepared from isolated cell nuclei.
Cells were suspended in lysis buffer (10 mM HEPES pH 7.9, 100 mM
KCl, and 1.5 mM MgCl2) and incubated for 15 min on ice. The cells
were disrupted with a Dounce homogenizer (25–30 tight pestle strokes)
and the nuclei were collected (at 650 3 g for 10 min at 48C). Nuclei
were suspended in 23 packed nuclei volume of buffer I and sonicated.
DNase/RNase cocktail I was added, followed by incubation for 1 hr at
RT and overnight at 48C. The extract was centrifuged at 14,000 3 g and
the supernatant was filtered (0.2 lm) prior to loading onto the gel filtra-
tion column; 1.5–3 ml of filtered cell extract was loaded on a Sephacryl
S-300 HR column using an A¨kta fast protein liquid chromatography
(FPLC) system (GE Healthcare) at 48C. The DNA fragments in the
extracts after sonication, DNase treatment, and filtration were smaller
than 100 base pairs as determined by agarose gel and ethidium bromide
staining. The column was equilibrated and run at a flow rate of 0.5 ml/
min using buffer II. Fractions of 5 ml were collected and used for IP.
High molecular weight and low molecular weight gel filtration calibra-
tion kits from GE Healthcare were used as molecular weight (MW) indi-
cators.
Immunoprecipitation (IP) andWestern Blot Analysis
For IP, antibodies that were covalently linked to protein-A paramag-
netic beads were incubated with the respective extracts in 5 ml of IP so-
lution at 48C overnight under constant rotation. The beads were collected
and suspended in 1 ml of 10 mM Tris—HCl pH 7.5, 100 mM KCl (IP
of total cell extracts) or buffer II (gel filtration) and washed 43 in 1 ml
of these buffers. The beads were used in the BER assay (described
below) or suspended in loading buffer, heated, separated on Bis-Tris—
HCl NuPAGE ready gels (4–12%, Invitrogen) and transferred to PVDF
membranes (Immobilon, Millipore). The membranes were blocked in 5%
low fat dry milk in PBST (PBS with 0.1% Tween 20), incubated with
primary antibodies in 1% dry milk at 48C overnight, and incubated 1 hr
with secondary antibodies. Membranes were then treated with Chemilu-
minescence reagent (SuperSignal West Femto Maximum, PIERCE) and
the proteins visualised using a Kodak Image Station 2000R.
BER Assay
We prepared DNA substrates for the BER assay containing uracil or a
synthetic analogue of an AP site (3-hydroxy-2-hydroxymethyltetrahydro-
furan, THF) at a single position (Supporting Information Figure S1C). A
normal AP site (indicated as X in Supporting Information Figure S1C)
was generated by incubating uracil-containing DNA substrate with puri-
fied catalytic domain of UNG [Slupphaug et al., 1995]. BER assays were
carried out essentially as described [Frosina et al., 1999; Akbari et al.,
2004] with some modifications. Specifically, we used 10 lM dATP, 10
lM dGTP and 10 lM dTTP, 62.5 nM dCTP and 8.3 nM [a-33P]dCTP (5
lCi/pmol dCTP). The incubation time was 15 min at 328C. The repaired
DNA substrate was digested with the indicated restriction enzymes and
analysed by denaturing polyacrylamide gel electrophoresis followed by
phosphor imaging (Fuji, BAS-1800II) of the dried gel. We used AP:A
DNA substrate (containing an AP site at position 50 adjacent to X),
[a-33P]dTTP and XbaI/HincII digestion for analysis of first nucleotide
incorporation, or [a-33P]dCTP and XbaI/HincII digestion for identifica-
tion of second nucleotide. For comparison of normal AP site (AP:A) and
THF, we used [a-33P]dTTP and BamHI/Pst I digestion to detect first nu-
cleotide insertion and amount of ligated product. Use of the same sub-
strates with [a-33P]dCTP and BamHI/PstI digestion detected incorpora-
tion of second nucleotide and amount of ligated product.
RESULTS
Gel Filtration of Nuclear Extracts Identifies XRCC1-EYFP
in Complexes with Large Differences in Size and
Composition
XRCC1 is associated with the replication machinery
where it directly interacts with PCNA [Fan et al., 2004]
and UNG2 [Akbari et al., 2010]. However, XRCC1-foci
are also detectable in nontreated non-S-phase cells, and
these foci contain neither PCNA nor UNG2 [Fan et al.,
2004; Akbari et al., 2010]. The content and nature of
XRCC1 complexes in such foci have not yet been
described. Here, we explore the presence, size, composi-
tion, and recruitment of XRCC1 and its interacting pro-
teins in different complexes in freely cycling, nontreated
cells.
We first established a HeLa cell line stably expressing
near endogenous levels of EYFP-tagged functional XRCC1
(XRCC1-EYFP) (Supporting Information Figures S1A and
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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S1B). From these cells, we prepared DNase/RNase
digested total nuclear extracts to explore whether we
could identify XRCC1 in large stable complexes. We
applied gel filtration to separate proteins and protein
complexes according to their relative molecular weight
and collected fractions containing proteins in the range
of 70–2000 kDa. To be able to detect XRCC1 associ-
ated proteins in the different fractions, we had to
enrich the fractions by immunoprecipitation. XRCC1-
EYFP and its associated proteins were pulled down
from each fraction using a-GFP coupled beads and an-
alyzed for protein content and ability to repair AP sites
(Figs. 1A and 1B). Importantly, these studies revealed
the presence of XRCC1-EYFP in complexes of differ-
ent sizes and composition. We found that immunopreci-
pitates from fractions 5 through 11 (approximately
700–350 kDa) had the highest capacity to cleave at an
AP site and incorporate nucleotides (Figs. 1A and 1B).
These immunoprecipitates contained detectable Lig III,
POLd, XRCC1, PNK, POLb, and PCNA. We could not
detect APE-1 by Western analysis (data not shown);
however, the immunoprecipitates clearly contained AP-
endonuclease activity suggesting the presence of the
protein (Fig. 1B).
UNG2 and XRCC1 were found in both large and small
complexes (Fig. 1A, fractions 2–4 and 12–16). We have
shown that XRCC1 interacts directly with UNG2, that
UNG2 and XRCC1 are in the same complex only in
S-phase, and that this complex is large and contains many
proteins [Akbari et al., 2010]. Thus, the small UNG2-
XRCC1 complexes may be an example of protein interac-
tions and complexes not present in situ, but an artefact
from the IP procedure as seen previously [Akbari et al.,
2010]. Thus, even if the exact content of proteins in the
immunoprecipitated complexes shown in Figure 1A does
not reflect the real in vivo situation, as these complexes
can be made or broken down during immunoprecipitation,
the gel filtration experiment clearly shows that XRCC1 is
found in complexes with sizes from 150 to 1500 kDa.
XRCC1-EYFPAssociated Complexes Have LP BER Activity
Immunoprecipitated XRCC1 complexes from S-phase
cells have been shown to perform rapid SP BER of ura-
cil and AP sites [Akbari et al., 2010]. The gel filtration
Environmental and Molecular Mutagenesis. DOI 10.1002/em
Fig. 1. Western blot analysis of immunoprecipitates from size fractio-
nated XRCC1-EYFP expressing HeLa nuclear extract and functional
BER analyses of XRCC1-EYFP complexes. (A) The gel filtration stand-
ards (blue dextran, thyroglobin, ferritin, and catalase) indicate the molec-
ular weight of the fractions. The total protein content in each fraction is
illustrated as a curve of ultraviolet light (UV) absorption (280 nm).
Immunoprecipitates from fractions 1 to 16 were prepared using a-GFP
couplet magnetic beads and subjected to Western blot. (B) DNA repair
synthesis analysis of the immunoprecipitates from gel filtration fractions
1–16 using AP:G substrate (illustrated in Supporting Information Figure
S1C) and [a-33P]dCTP, followed by digestion of purified DNA with
XbaI/HincII to detect incorporation of the first nucleotide. The y axis
shows repair synthesis as arbitrary units. Shown below the fraction num-
bers is a representative gel depicting the labeled DNA product. (C)
Time-dependent inhibition of DNA repair synthesis activity of XRCC1-
EYFP immunoprecipitates from un-fractionated XRCC1-EYFP express-
ing HeLa nuclear extract by NEM (10 mM). We used AP:A DNA
substrate (containing an AP site at position 50 adjacent to X shown in
Supporting Information Figure S1C), [a-33P]dTTP and digestion of the
product with XbaI/HincII to measure first nucleotide incorporation, or
[a-33P]dCTP and digestion of DNA with XbaI/HincII to detect incorpo-
ration of second nucleotide. (D) BER was carried out for 15 min using a
normal AP site (AP:A) or THF (THF:A) DNA substrates. Using
[a-33P]dTTP in the assay and digestion of the product with BamHI/PstI
detects the first nucleotide incorporation and amount of ligated product.
Use of the same substrates and [a-33P]dCTP and digestion of the DNA
with the same enzymes detects incorporation of the second nucleotide.
One representative set of data from three experiments is shown.
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experiment suggested that XRCC1-associated complexes
contain both POLb and POLd, a polymerase typically
associated with LP BER (Fig. 1A). We therefore exam-
ined whether immunoprecipitated XRCC1 complexes
from freely cycling cells could perform LP BER using
synthetically defined, circular plasmid DNA substrates.
We used N-ethylmaleimide (NEM) to examine the re-
spective roles of POLb and POLd in the DNA repair
synthesis activity of XRCC1-EYFP immunoprecipitates.
At the concentration used here, adding NEM to the
repair reaction inhibits POLd and several other enzymes
but not POLb [Krokan et al., 1979]. Adding NEM inhib-
ited first nucleotide insertion activity by 27% after 15
min of repair, while the degree of inhibition was 57%
after 45 min (quantified from the gel in Fig. 1C, left
panel). Incorporation of the second nucleotide increased
with time in the absence of NEM (up to 20% of total
incorporation) but could not be detected in the presence
of NEM (Fig. 1C, right panel), suggesting that incorpora-
tion of the second nucleotide was performed exclusively
by POLd. Also, neutralising antibodies against POLb
strongly inhibited the total BER capacity (nucleotide
insertion and ligation) of the XRCC1-EYFP immunopre-
cipitates after 15 min of repair (Supporting Information
Figure S1C). Together, these results suggest that in the
XRCC1-EYFP complexes, POLb is more important for
the initial single nucleotide BER reaction, while POLd is
more important after prolonged incubation and for LP
repair synthesis.
To further explore the LP BER activity of XRCC1
complexes, we used a 3-hydroxy-2-hydroxymethyltetrahy-
drofuran (THF) synthetic AP site substrate. The lyase ac-
tivity of POLb is unable to remove 50-THF residues after
APE-1 incision because this lesion is resistant to b-elimi-
nation. Thus, repair of THF residues requires LP BER
and 50-flap-endonuclease activity [Kim et al., 1998]. The
presence of LP BER activity in the XRCC1-EYFP com-
plexes was further analyzed by comparing the repair of
DNA substrates containing a normal AP site with sub-
strates containing THF. We analyzed the incorporation of
one or two nucleotides and the ability to complete repair
(see figure legend and Fig. S1C). Incubating the immuno-
precipitated XRCC1-EYFP complexes with the THF sub-
strate in the presence of [a-33P] TTP (detects first nucleo-
tide) revealed that a fraction of the repair patch is
repaired, including ligation, although in contrast to the
normal AP site substrate, a fraction remained unligated in
the time frame analyzed (Fig. 1D, compare lanes 1 and
2). This indicates that, although present, LP BER is less
efficient than SP BER. As would be expected, a consider-
able amount of the completely repaired THF substrate
consisted of a minimum of two nucleotide insertion prod-
ucts (same substrates in the presence of [a-33P] CTP), fur-
ther supporting the ability of XRCC1-EYFP complexes to
perform LP BER (Fig. 1D, lane 4).
XRCC1, POLb, and PNKColocalize with PCNA in
Replication Foci
Next, we wanted to study the localisation of the differ-
ent XRCC1-complexes in vivo using live, freely cycling
cells expressing XRCC1-EYFP. Recently, low amounts of
POLb and PNK were found in XRCC1-EYFP complexes
immunoprecipitated from S-phase cells, suggesting their
presence in replication associated XRCC1 complexes
[Akbari et al., 2010]. POLb has been reported to interact
with PCNA in vitro [Kedar et al., 2002]; however, neither
POLb nor PNK have been shown to colocalize with repli-
cation foci in live untreated cells.
Stable XRCC1-EYFP–expressing cells were transfected
with POLb-ECFP or PNK-ECFP and a HcRed-tagged
PCNA as an S-phase marker [Leonhardt et al., 2000]
(Fig. 2). The white spots in S-phase cells indicate colocal-
ization of POLb or PNK with both XRCC1 and PCNA,
whereas yellow spots contain only POLb or PNK and
XRCC1 (Figs. 2D and 2H). Thus, our results identify
XRCC1-foci containing PNK and POLb both outside
(yellow) and within replication foci (white) in S-phase
cells. We identified a similar colocalization pattern in
early, mid- and late S-phase cells judged by the pattern of
PCNA foci described previously [Leonhardt et al., 2000]
(data not shown).
DNADamage Induced XRCC1-Foci Contain POLb and
PNK, But Not PCNA
Neither PCNA nor UNG2 is found in XRCC1-foci in
undamaged non-S-phase cells [Fan et al., 2004; Akbari
et al., 2010]. XRCC1-foci lacking PCNA possibly repre-
sent sites of ongoing SSBR/SP BER of endogenously gen-
erated DNA damage, e.g., of the more than the 104 AP
sites that are believed to be generated per cell per day, or
they may represent constitutively present DNA repair
complexes in the absence of DNA damage. However,
PCNA was previously reported to colocalize with XRCC1
in micro-irradiation induced foci (UV-A; 365 nm, the
exact dose used in this experiment was not specified)
[Lan et al., 2004]. Thus, whether PCNA is present only at
DNA–damage induced foci or whether its presence
depends on the type of DNA damage is unclear. In this
study, we determined the presence of different BER pro-
teins, including POLb, PNK, PARP-1, FEN-1, and
PCNA, in XRCC1-foci before and after micro-irradiation
of two regions with ‘‘high’’ or ‘‘low’’ doses of a 405-nm
laser (energy output is given in Materials and Methods).
The role of XRCC1 in the recruitment of DNA repair
proteins to sites of DNA damage was first examined using
the XRCC1 deficient Chinese hamster ovary cell line
(CHO EM9), its parental wild-type cell line (AA8), and
CHO EM9 cells expressing human XRCC1-EYFP. We
found that localization of POLb to sites of irradiation was
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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completely dependent on XRCC1, while the recruitment of
PNK, PCNA, and PARP-1 were enhanced in the presence
of XRCC1 or overexpressed human XRCC1-EYFP (Table
I). The increased recruitment of PARP-1 in the presence of
overexpressed XRCC1-EYFP, compared with AA8 carrying
endogenous levels of XRCC1, may be due to direct interac-
tion between PARP-1 and overexpressed XRCC1.
We next performed experiments in HeLa cells. We
detected constitutively present XRCC1 foci in undamaged
non-S-phase cells that colocalized with POLb, PNK, and
to a more variable degree PARP-1, but not with PCNA
(Figs. 3A–3C, and Supporting Information Figure S2A,
foci encircled). POLb, PNK, and PARP-1 are generally
considered as SSBR/SP BER proteins, and thus, these
foci likely represent complexes carrying out SP repair
reactions. When micro-irradiating a selected region with a
low dose (10 iterations, see Materials and Methods), we
could detect multiple XRCC1-foci in this region within
15 sec (not shown). POLb and PNK were recruited to
these foci in a similar manner as XRCC1, and the foci
reached highest intensity after 60–90 sec (Figs. 3A and
3B, the irradiated regions are shown with arrows). Also,
multiple additional XRCC1 foci outside the irradiated
region (distal XRCC1-foci) emerged (Figs. 3A–3C).
These foci were also detected within 15 sec after irradia-
tion, suggesting that they may arise due to rapid intracel-
lular stress signals, possibly mediated by ROS [Bedard
and Krause, 2007; Yalcin et al., 2010; Ha et al., 2011].
PARP-1 foci could be detected 3 min post-irradiation at
low doses (Fig. 3C, mid row, inset). Increasing the dose
of micro-irradiation 15-fold (150 iterations) generated
stronger XRCC1-foci, and PARP-1 foci could be detected
after 60–90 sec (not shown), becoming brighter and easily
detectable after 3 min (Fig. 3C, lower row). The same
pattern of recruitment was seen when cells were irradiated
in the nucleolar region, even though these regions contain
higher levels of PARP-1 (data not shown). These results
imply that recruitment of XRCC1 is independent of
PARP-1; however, because HeLa cells have high levels
of endogenous PARP-1, the total amount of PARP-1
needed at the site of DNA damage could also be saturated
by endogenous untagged PARP-1.
Next, we examined the recruitment of the LP BER pro-
teins, PCNA and FEN-1, to XRCC1-foci induced by
micro-irradiation. Detection of PCNA and FEN-1 at the
site of micro-irradiation required 10- to 15-fold higher
doses (defined here as our ‘‘high dose’’) than needed for
detection of the SSBR/SP BER proteins POLb, PNK, and
PARP-1 (Figs. 3D and 3E). Additionally, PCNA is not
normally found in XRCC1-foci in undamaged non-S-
phase cells (Supporting Information Figure S2A and [Fan
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Fig. 2. Colocalization of POLb and PNK with XRCC1 in replication
foci. (A–D) Cotransfection of HeLa cells expressing XRCC1-EYFP with
ECFP-POLb or (E–H) ECFP-PNK together with HcRed-tagged PCNA
as a replication marker. White spots (merged) demonstrate colocalization
of POLb, XRCC1, PCNA (D) and PNK, XRCC1, PCNA (H). Yellow
spots show colocalization of POLb and XRCC1 (D) and PNK and
XRCC1 (H). Bars, 5 lm.
TABLE I. Micro-Irradiation in Three Different Cell Lines with
Different Levels of XRCC1
Proteins
EM9
(Xrcc12/2)
AA8
(Xrcc11/1)
EM9 XE
(XRCC1-EYFP)
POLb 2 11 11
PNK 1 11 11
PCNA (1) 1 1
PARP 1 1 11
11 5 Foci after micro-irradiation with low dose; 1 5 Foci after
micro-irradiation with high dose; (1) 5 Weak foci after micro-irradia-
tion with high dose.
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et al., 2004; Akbari et al., 2010], suggesting that LP BER
proteins are recruited mainly after more extensive DNA
damage. These results show that application of an appro-
priate dose of micro-irradiation is crucial and should be
carefully determined in these types of studies; otherwise
there is a risk of drawing faulty conclusions related to
relocation and involvement of different repair proteins in
repair of different DNA damage.
Since irradiation of cells with UV-A beams (320–400
nm) generates reactive oxygen species (ROS), pyrimidine
dimers, and double strand breaks (DSBs), depending on
the intensity and dose of irradiation [Herrlich et al.,
2008], we further explored whether the doses of micro-
irradiation used herein induced the formation of DSBs by
staining irradiated HeLa cells with antibodies against
gH2AX (a marker of DSBs). We found that irradiation of
HeLa cells with our ‘‘high dose’’ did not induce gH2AX
staining, while irradiating larger regions with doses
exceeding our ‘‘high dose’’ in the same dish gave posi-
tive staining (Fig. 3F, white arrows show foci after ‘‘high
dose’’ irradiation, red and orange arrows show foci after
irradiation with 4- and 10-fold higher laser doses, respec-
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Fig. 3. Recruitment of XRCC1, POLb, PNK, PARP-1, FEN-1, and
PCNA to micro-irradiated regions. Cotransfection of HeLa cells with
XRCC1-ECFP and EYFP-POLb (A), XRCC1-EYFP and ECFP-PNK
(B), XRCC1-ECFP and EYFP-PARP-1 (C), XRCC1-ECFP and EYFP-
PCNA (D), XRCC1-ECFP and EYFP-FEN-1 (E), XRCC1-EYFP and
gH2AX staining (F). Micro-irradiation was performed on selected
regions of interest with different number of iterations (it) of 1.25(lsec
irradiation/pixel (100% output 405 nm laser). White arrows: 50 3 2 pix-
els, 10 it (‘‘low dose’’) or 150 it (‘‘high dose’’). Red arrow: 250 3 2
pixels, 600 it. Orange arrow: 150 3 2 pixels, 1500 it. Circles indicate
constitutive foci. Bars, 5 lm.
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tively). Since a higher dose (53) was required to induce
XRCC1 foci in CHO cells compared to HeLa cells, the
dose found to promote the recruitment of PCNA in CHO
(i.e., 600 laser beam iterations, Table I) might have
actually introduced DSBs.
Analogous to the recruitment of BER proteins to low-
dose micro-irradiated regions, XRCC1-foci induced by
low doses of MMS or H2O2 contained POLb and PNK,
but not PCNA (Supporting Information Figure S2), sug-
gesting that the type of DNA damage induced by these
three treatment paradigms is comparable. However, the
type of DNA damage is not identical in the three cases,
as illustrated by the observation that H2O2 and MMS-
induced XRCC1-foci displayed different kinetics
(Supporting Information Figure S3B).
Inhibition of PARylation Causes Only Minor Changes to
the Recruitment of SP BER Proteins to Damaged Regions
after Low Dose Micro-Irradiation
Our results (Table I and Fig. 3C) indicate that the level
of XRCC1 in the foci affects the recruitment and/or the
retention of PARP-1 in micro-irradiated regions. To
explore whether this was due to the level of polyADP-
ribosylation (PARylation), we examined the effect of
PARP-inhibitors on the recruitment of DNA repair pro-
teins to the site of DNA damage. We carried out the
same experiments as in Figure 3, but in the presence of a
PARP-inhibitors (either 4-amino-1,8-naphthalimide (4-
AN) or N-(5,6-dihydro-6-oxo-2-phenanthridinyl)22-aceta-
mide hydrochloride (PJ34)). 4-AN and PJ34 have been
used in several studies examining the role of PARP and
PARylation in BER as well as in in vivo models [Abdel-
karim et al., 2001; Godon et al., 2008; Heacock et al.,
2010; Jelezcova et al., 2010]. In the experiments, we used
10 lM of either PARP-inhibitor. This was a concentration
that was sufficient and necessary for total abolishment of
nuclear PARylation in MMS-treated HeLa cells (Sup-
porting Information Figure S4). Inhibition of PARylation
is believed to inhibit dissociation of PARP-1 from DNA,
as it has been shown that treatment of 4-AN leads to
increased accumulation of PARP-1 and PCNA at sites of
micro-irradiation [Godon et al., 2008].
We found that in the presence of 4-AN, PARP-1 foci
were detected immediately after low dose micro-irradia-
tion (15 sec, Fig. 4A, mid row, inset). This observation
suggests an increase in PARP-1 accumulation compared
with what can be observed in the absence of 4-AN (com-
pare with Fig. 3C). However, this outcome was not the
case when treating cells with PJ34, although PJ34 also
inhibits PARylation. To detect EYFP-PARP-1 at sites of
micro-irradiation in PJ34 treated cells, a 15-fold higher
dose of laser irradiation was required (Fig. 4B). Thus, in-
hibiting PARylation is not likely the underlying mecha-
nism for the accumulation of EYFP-PARP-1 at sites of
DNA damage, and instead, it may involve a 4-AN medi-
ated change in the affinity of PARP-1 for DNA.
Interestingly, we found that inhibition of PARylation
by 4-AN or PJ34 only caused a minor reduction in the
recruitment of XRCC1 (Figs. 4A and 4B, left panel). The
recruitment of XRCC1 is slightly reduced at the high irra-
diation dose in the presence of 4-AN, but not reduced at
low dose irradiation. Recruitment of XRCC1 is not seen
at low dose irradiation and is slightly reduced at high
dose in the presence of PJ34 (compare Fig. 3C with Figs.
4A and 4B).
An increased recruitment of both PCNA and FEN-1
was detected in the presence of 4-AN (compare Figs. 3D
and 3E with Figs. 4C and 4D), while no (low dose) or
very little (high dose) effect of 4-AN treatment was seen
for recruitment of XRCC1, POLb, or PNK (data shown
only for XRCC1). Thus, the small change observed at
high dose affected all three proteins similarly, suggesting
that these repair proteins are regulated similarly and are
found in a same sub-complex. PCNA and FEN-1 recruit-
ment was not significantly changed by PJ34 treatment of
the cells (compare Figs. 3D and 3E with Figs. 4E and
4F); thus the increase in PCNA and FEN-1 recruitment
by 4-AN treatment is likely connected to an increased
accumulation of PARP-1 at the site of DNA damage. Our
results clearly show that XRCC1/PNK/POLb are recruited
to sites of DNA damage independent of PARP-1 accumu-
lation and PARylation, and interestingly, that different
PARP-inhibitors affect DNA repair protein recruitment
differently.
DISCUSSION
BER corrects a variety of DNA base lesions and SSBs
that are constantly generated by endogenous and environ-
mental agents. The fact that BER can be reconstituted
in vitro by a few ‘‘core proteins’’ has contributed to a
rather simplified notion of BER. However, in recent years,
new findings have given rise to a more complex view of
this repair pathway [Hegde et al., 2008]. For instance,
PCNA and XRCC1 interact with a number of DNA repair
proteins and have been suggested to provide a platform
for the organization of DNA repair [Mortusewicz and
Leonhardt, 2007]. Our aim for this study was to further
elucidate the role of XRCC1 in orchestrating cellular
BER/SSBR.
Western blotting of XRCC1-EYFP immunoprecipitates
from gel filtration fractions identified the presence of
XRCC1 in complexes of sizes between 70 and 2000 kDa.
Immunoprecipitates from fractions containing protein
complexes with molecular weights between 350 and 700
kDa exhibited the highest repair capacity. Furthermore,
we showed that immunoprecipitated XRCC1 complexes
from unfractionated nuclear extracts possessed both SP
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and LP BER capacity. The theoretical molecular weight
of an XRCC1 repair complex containing all proteins nec-
essary to carry out both complete SP and LP BER, i.e.,
Lig III (103 kDa), Lig I (125 kDa), XRCC1 (70 kDa),
APE-1 (35 kDa), FEN-1 (48 kDa), PCNA (32 kDa), and
POLb (39 kDa) or POLd (125 kDa), is between 350 and
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Fig. 4. Recruitment of XRCC1, PARP-1, FEN-1, and PCNA to micro-
irradiated regions in absence and presence of 4-AN and PJ34. Cotrans-
fection of HeLa cells with XRCC1-ECFP and EYFP- PARP-1 in the
presence of 4-AN (A), XRCC1-ECFP and EYFP-PARP-1 in the pres-
ence of PJ34 (B), ECFP-PCNA and EYFP-PARP-1 in the presence of
4-AN (C), ECFP-FEN-1 and EYFP-PARP-1 in the presence of 4-AN
(D), ECFP-PCNA and EYFP-PARP-1 in the presence of PJ34 (E),
ECFP-FEN-1 and EYFP-PARP-1 in the presence of PJ34 (F). Micro-
irradiation was performed on selected regions of interest (ROI) with
size 50 3 2 pixels. These are marked with white arrows; 10 (low dose)
or 150 (high dose) iterations of 1.25 (lsec irradiation/pixel (100% out-
put 405 nm laser) were used. Arrows indicate irradiated regions. Bars,
5 lm.
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600 kDa. Our gel filtration results are different from a
previous report where fractionation of cell extracts only
detected XRCC1 in small complexes [Parsons et al.,
2005a]. Although we are currently unable to explain these
discrepancies, the differences in the methods used for the
preparation of cell extracts (e.g., we used DNase/RNase
treated nuclear extracts), as well as the conditions of gel
filtration, are among the plausible causes.
In a number of studies designed to elucidate the organi-
zation of BER and the recruitment of BER proteins to
sites of DNA damage, either the exact dose of irradiation
was not specified or very high doses of the DNA damag-
ing agent (like H2O2 or micro-irradiation) were used rela-
tive to the doses we have used in this study [Lan et al.,
2004; Mortusewicz et al., 2006, 2007; Godon et al.,
2008]. This may have two important consequences. First,
a direct comparison of results from different studies is
hampered by the shortage of information about the experi-
mental conditions. Second, as we have shown herein, the
dose of the DNA-damaging agent has a pivotal effect on
the observed recruitment of repair proteins. Similar con-
cerns have been raised for induction of DSBs by irradia-
tion [Bekker-Jensen et al., 2006; Kong et al., 2009].
Our data herein indicate that XRCC1 is present in at
least three categories of foci, likely involving several dif-
ferent sub-types of XRCC1 complexes: (i) XRCC1 com-
plexes colocalizing with PCNA in replication foci; (ii)
XRCC1-complexes that are rapidly formed after treatment
of cells with low dose micro-irradiation, H2O2, or MMS
and that are present in untreated cells independent of the
cell cycle likely repairing spontaneous DNA damage; and
(iii) XRCC1-complexes that are formed after treatment
with high dose micro-irradiation or other DNA damaging
agents causing high levels of DNA strand breaks. The
type of DNA damage and/or cell signalling induced by
the dose of micro-irradiation, MMS, or H2O2, as well as
the cell cycle stage, appears to dictate which XRCC1
complex partner(s) are recruited. For example, recruitment
of LP BER proteins such as FEN-1 and PCNA required
10–15-fold higher doses of micro-irradiation and which
presumably leads to higher levels of ROS and SSBs.
Studies have begun to reveal that there may exist three
modes of BER/SSBR (summarized in Fig. 5). For sim-
plicity only a limited number of proteins and only the
BER proteins we have focused on in this and previous
work [Akbari et al., 2010] are included in the model. We
classify the first mode as ‘‘classic BER’’, involving coor-
dinated hand-off of the substrate/product from the initiat-
ing DNA glycosylase to APE-1 to POLb/PNK/XRCC1/
Lig III multi-protein complexes (Mw  350 kDa). Classic
BER would presumably handle any general genome dam-
age at levels that fall within the repair capacity of the
cell, e.g., endogenous AP sites, base damages, and SSBs,
as well as most DNA damage introduced by low-dose
micro-irradiation, H2O2, and MMS. Interestingly, we
found that the XRCC1 complexes immunoprecipitated
from fractions containing protein complexes between 350
and 700 kDa have the highest repair capacity (Fig. 1).
Because we detected PARP-1 in a fraction of constitutive
XRCC1-foci in the absence of exogenous damage, as well
as low levels of PARP-1 in XRCC1-foci after low-dose
micro-irradiation (Fig. 3C) and in XRCC1-complexes iso-
lated from S-phase [Akbari et al., 2010], PARP-1 and
other proteins may also be part of these complexes. How-
ever, the classic repair process likely would not engage
PARP-1 and PARylation directly, unless it is interrupted
and repair intermediates are exposed; thus this repair
mode will not be directly affected by inhibition of PARy-
lation.
The second BER/SSBR mode (Fig. 5) would be more
specific for higher levels of DSBs, direct or indirect, that
exceed cellular repair capacity for rapid repair and may
therefore bind PARP-1 as a protective mechanism, as sug-
gested previously [Parsons et al., 2005b; Strom et al.,
2010]. In this case, subsequent PARylation facilitates the
recruitment of repair proteins to the damaged site via
interactions through their different PAR-interacting
domains, leading to activation of intracellular signalling
and inhibition of transcription, etc. Staining for gH2AX
were negative after micro-irradiating with our ‘‘high
dose,’’ thus we were not introducing DSBs but likely
DNA damage repaired by BER/SSBR complexes. How-
ever, we detected an increased recruitment of PARP-1,
FEN-1, and PCNA using ‘‘high dose’’ irradiation, which
may suggest introduction of DNA damages other than
those created with ‘‘low dose.’’ The dependence upon
PARylation will likely increase with increasing levels of
strand breaks; however, because PARP-1-deficient cells
do repair SSBs efficiently [Vodenicharov et al., 2000] and
90% of the cell’s PARylation activity is due to PARP-1
[Megnin-Chanet et al., 2010], it is not essential for repair.
The third mode of BER (Fig. 5) would involve larger
protein complexes (>700 kDa) and is associated with the
DNA replication machinery as described in our previous
study [Akbari et al., 2010], where we identified two repli-
cation associated BER complexes with different protein
content: (1) UNG2 associated complexes containing more
POLd and Lig I and (2) XRCC1 associated complexes
containing more Lig III, POLb, PARP-1, and PNK. These
complexes had significant differences in their repair activ-
ities. Here, we verify the presence of POLb and PNK in
these XRCC1-complexes in vivo. A close association of
BER with DNA replication is likely important for genome
maintenance, and as such, XRCC1 may have an important
role in facilitating BER in the vicinity of the replication
fork, probably at both pre- and post-replication com-
plexes. As we did not observe localisation of UNG2 in
XRCC1-foci of non-S-phase cells [Akbari et al., 2010],
and because UNG2, MPG, or hOGG1 are not recruited to
XRCC1 foci after micro-irradiation (data not shown), we
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conclude that these DNA glycosylases are not always a
stable partner of XRCC1 complexes even though they do
interact with XRCC1 [Marsin et al., 2003; Campalans
et al., 2005; Akbari et al., 2010].
Surprisingly, we found that the two PARP-inhibitors,
4-AN and PJ34, affected PARP-1 recruitment and/or
accumulation at sites of DNA damage differently after
micro-irradiation. Although the molecular basis for this
difference is unclear, we did find that PARylation was
dispensable for subsequent protein recruitment, and that
the amount of PARP-1 present at the site of DNA damage
affected the repertoire of repair proteins recruited, as
shown for PCNA and FEN-1. An increased sensitivity to-
ward MMS is seen when treating cells with PJ34 [Jelez-
cova et al., 2010], and PJ34 exposure does not lead to
accumulation of PARP-1 at sites of DNA damage (Figs.
4B–4E); thus, the hypothesis that PARP inhibition reduces
BER because of an accumulation of PARP-1 at the site of
DNA damage due to lack of PARylation [Godon et al.,
2008] has to be reconsidered. Recently, the function of
PARP-1 in BER/SSBR [Jelezcova et al., 2010; Strom
et al., 2010], in signal transduction [Stilmann et al.,
2009], chromatin remodelling, and in regulating transcrip-
tion [Godon et al., 2008; Lonn et al., 2010] has been
reconsidered. The overall message is that several impor-
tant cellular regulatory mechanisms are likely to be
directed by PARylation, and consequently also influenced
by PARP-inhibition. This fact makes it difficult to inter-
pret the actual function of the PARylation in SSBR/BER.
As targeting PARylation in cancer therapy is showing
great promise, knowledge about the cellular consequences
of inhibition of PARylation is becoming more important.
Thus, our results have implications for future design of
DNA repair studies as well as for our understanding of
the molecular mechanisms of PARP-inhibitors.
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